Monday, 31 August 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

EIDESVIK OFFSHORE Stock Bullish By 30% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of EIDESVIK OFFSHORE (Oslo Børs Benchmark Index_GI: EIOF.OL) rose by a staggering 30.49% in 21 sessions from kr11.02 to kr14.38 at 16:26 EST on Wednesday, after three consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI is sliding 0.18% to kr1,243.03, after two sequential sessions in a row of losses.

About EIDESVIK OFFSHORE

Eidesvik Offshore ASA operates as a shipping company in Norway. It operates through Supply, Subsea/Wind, and Seismic segments. The company delivers shipping services to customers who produce seismic data; subsea inspection, maintenance, repair, and construction services for subsea work in the oil industry; and shipping services to the offshore oil industry. It operates 8 large supply vessels; a fleet of 4 vessels related to seismic; and a fleet of 4 vessels related to subsea/wind. The company was founded in 2004 and is headquartered in Bømlo, Norway. Eidesvik Offshore ASA operates as a subsidiary of Eidesvik Invest AS.

Earnings Per Share

As for profitability, EIDESVIK OFFSHORE has a trailing twelve months EPS of kr-1.99.

More news about EIDESVIK OFFSHORE (EIOF.OL).

Categories

stockMarket

Tags

Stock PriceMarket Session NowEIOF.OLStock Market NowPrice UpMarket SessionStock Price UpStock MarketEIDESVIK OFFSHOREStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com